ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ANDG vs HQY // EV/EBITDA & P/E VALUATION

Andersen Group Inc. (Class A) (NYSE) VS. HealthEquity Inc. (NASDAQ) • 15-METRIC TALLY: ANDG 4 — HQY 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANDG VS. HQY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ANDG HQY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 69.50% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -28.90% 9.30% -38.20 HQY /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 27.8x — TIE /valuation <GO>
Free Cash Flow Yield 2.36% 5.43% -3.07 HQY /fcf-yield <GO>
Operating Margin -16.10% 24.60% -40.70 HQY /operating-margins <GO>
Net Profit Margin -0.30% 16.40% -16.70 HQY /net-margins <GO>
Revenue Growth (YoY) 14.60% 9.50% +5.10 ANDG /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 2.87% 0.00% +2.87 ANDG /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.29 4.86 +3.43 ANDG /balance-sheet <GO>
Piotroski F-Score Quality 5/9 9/9 -4.00 HQY /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 72.3 62.4 +9.88 ANDG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.96 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $7.39B $8.38B -$991.9M HQY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ANDG REV HQY REV ANDG GROSS % HQY GROSS % ANDG FCF HQY FCF
FY 2025 $838.7M $1.31B — 69.5% $174.3M $455.1M
FY 2024 $731.6M $1.20B — 64.8% $143.7M $337.8M
FY 2023 $639.1M $999.6M — — $118.1M $197.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANDG // BETA —
HQY // BETA 0.96